Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

GetRelief Rx Tirzepatide Review: Sublingual-Only & Honest Verdict (2026)

An honest 2026 review of GetRelief Rx tirzepatide — sublingual drops only, a delivery method not studied in trials, and a Cloudflare-blocked review attempt.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Found

Established, physician-designed weight care with a broad formulary — real brand-name Zepbound/Mounjaro alongside compounded tirzepatide, paired with coaching.

$289/mo m2m ($169/mo on 12-mo prepay)

Check Found availability

The most important fact about GetRelief Rx: it offers sublingual drops only — no injectable option — a delivery method that wasn't the one studied in the SURMOUNT trials cited below. This review also attempted to independently verify the site and was blocked by a Cloudflare bot-detection challenge.

Sublingual only — a different delivery method than what was studied

GetRelief Rx offers compounded sublingual semaglutide (6mg, 9mg) and compounded sublingual tirzepatide (7.5mg, 13mg, 16mg) — drops, not injections. The pivotal SURMOUNT and STEP trials that established tirzepatide and semaglutide's efficacy studied the injectable form specifically; sublingual absorption of these peptides is a different route with its own open questions about bioavailability. This is worth understanding clearly before assuming the same results apply.

Live verification was blocked

This review attempted to independently confirm GetRelief Rx's current pricing and program details directly against getreliefrx.com. The site returned a security-challenge response with a Cloudflare "Just a moment..." bot-detection challenge, blocking automated verification. Every figure below was last verified on July 20, 2026.

§ GetRelief Rx — Delivery Method Mismatch

ItemStatus
Delivery methodSublingual drops only
Trials cited on this siteStudied the injectable formulation, not sublingual
Live verificationBlocked — Cloudflare bot-detection challenge
This review's live verification attempt was blocked by a Cloudflare bot-detection challenge.

What GetRelief Rx is

Get Relief RX, LLC is a Billings, Montana-based telehealth service. It publishes pricing publicly with no login required — a genuine transparency positive — and holds a BBB accreditation with an A rating (as of March 2026).

What GetRelief Rx costs

The 16mg tirzepatide dose runs $179/month, with a free online assessment and no upfront consultation fee.

A regulatory question worth reading up on

GetRelief Rx continues to sell compounded tirzepatide following the FDA's 2025 decision to end its shortage-based compounding enforcement discretion for tirzepatide. This is a nuanced, evolving regulatory area — read our full guide on whether compounded tirzepatide is still legal in 2026 rather than relying on this summary alone, since the legal basis for compounding this molecule has genuinely narrowed since 2024-2025.

How the care model holds up

GetRelief Rx's real strengths: publicly published pricing with no login wall, a BBB A rating, and a free assessment with no upfront consultation fee. The trade-offs are significant: it's sublingual-drops-only, a delivery method not studied in the pivotal trials; this review found no LegitScript, PCAB, or NABP pharmacy certification; prescriber credentials aren't specified beyond "licensed clinicians"; and it operates in a narrowing regulatory space for compounded tirzepatide specifically. This review's own attempt to verify any of it live was also blocked by a Cloudflare challenge. As with any GLP-1 program, and especially a sublingual one in a shifting regulatory landscape, read our compounding legal-status guide and confirm current terms directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

GetRelief Rx's transparent pricing and BBB rating are genuine positives but the sublingual-only delivery method wasn't the one studied in the trials this site cites, and this review couldn't verify anything live given a Cloudflare block. Read our compounding legal-status guide before committing to a sublingual compounded product. For an injectable option this review could independently verify live, compare CoreAge Rx or BiltRx. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

Does GetRelief Rx offer injectable tirzepatide?

No — sublingual drops only, a delivery method not studied in the pivotal SURMOUNT trials.

How much does tirzepatide cost through GetRelief Rx?

$179/month for the 16mg sublingual dose. This review could not independently reconfirm this live — the site is blocked by a Cloudflare bot-detection challenge.

Is GetRelief Rx LegitScript certified?

No — this review found no LegitScript, PCAB, or NABP pharmacy certification.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.